US insurance companies may not pay for new diabetic devices

doi:10.1136/bmj.320.7234.536/d

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Fred Charatan

Florida

Although medical device companies in the United States are forging ahead in developing new, non-invasive blood and tissue glucose monitors, insurance companies are proving unwilling or unable to pay for many of them.

The most advanced non-invasive device is the GlucoWatch Monitor, made by Cygnus of Redwood City, California, which is worn like a wristwatch. It uses a low level electric current to induce reverse iontophoresis.

This allows the monitor to collect glucose samples from interstitial tissue (not …